FDA Inspection 1100926 — Roche Molecular Systems, Inc.
The FDA completed an inspection of Roche Molecular Systems, Inc. on Jul 31, 2019 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 31, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Branchburg, NJ (United States)